ADVFN - Advanced Financial Network.
HOME» NYSE » V » VRX Stock Price » VRX Stock News

Valeant Pharma Share News

 Valeant Pharmaceuticals International Stock Price
VRX Stock Price
 Valeant Pharmaceuticals International Stock Chart
VRX Stock Chart
 Valeant Pharmaceuticals International Stock News
VRX Stock News
 Valeant Pharmaceuticals International Company Information
VRX Company Information
 Valeant Pharmaceuticals International Stock Trades
VRX Stock Trades

Sanofi Finalizes Sale Of Dermik To Valeant Pharmaceuticals

PARIS -(Dow Jones)- French drug company Sanofi-Aventis (SAN.FR) announced Monday the finalization of the sale of its Canadian dermatology business, Dermik, to Valeant Pharmaceuticals International Inc. (VRX) for $422.5 million. In a statement, Sanofi said the transaction includes an aesthetic and therapeutic business in the U.S. and Canada, as well as an aesthetic business around the world. Sanofi's Canadian unit will continue its operations in Greater Montreal, said the company. -By Nadya Masidlover, Dow Jones Newswires; +33 1 4017 1740; nadya.masidlover@dowjones.com

Stock News for Valeant Pharma (VRX)
DateTimeHeadline
05/24/201618:28:00SEC Reviewed Valeant's Use of 'Non-GAAP' Financial Measures...
05/24/201617:09:13Additional Proxy Soliciting Materials (definitive) (defa14a)
05/24/201614:30:00SEC Reviewing Valeant's Use of 'Non-GAAP' Financial Measures
05/24/201614:22:00SEC Reviewing Valeant's Use of 'Non-GAAP' Financial Measures
05/23/201607:00:00Bausch + Lomb Wins Walmart "Supplier of the Year" Award
05/23/201607:00:00Bausch + Lomb Wins Walmart "Supplier of the Year" Award
05/20/201618:20:00Valeant Investor Sequoia Fund to Limit Stakes in a Single Stock
05/20/201616:20:26Current Report Filing (8-k)
05/20/201606:07:08Current Report Filing (8-k)
05/19/201618:00:00Valeant Pharmaceuticals Receives Notice Of Default From Bondholders
05/19/201618:00:00Valeant Pharmaceuticals Receives Notice Of Default From Bondholders
05/18/201615:15:00Valeant Pharmaceuticals To Participate At The UBS Global Healthcare...
05/18/201615:15:00Valeant Pharmaceuticals To Participate At The UBS Global Healthcare...
05/18/201601:00:00Pharming Group: Interim Report on Financial Results for Q1 2016
05/16/201623:20:00Perrigo Updates First-Quarter Loss Figure to Reflect Lower Tax...
05/16/201619:00:00Valeant Pharmaceuticals Provides Update Regarding Regulatory...
05/16/201619:00:00Valeant Pharmaceuticals Provides Update Regarding Regulatory...
05/16/201618:59:09Current Report Filing (8-k)
05/16/201617:25:34Statement of Changes in Beneficial Ownership (4)
05/16/201617:05:20Statement of Changes in Beneficial Ownership (4)

Valeant Pharma and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad